This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Regulation of the evolutionarily conserved muscle myofibrillar matrix by cell type dependent and independent mechanisms
Nature Communications Open Access 13 May 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original articles
Teerlink, J. R. et al. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2025797 (2020)
Saberi, S. et al. Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM CMR substudy analysis. Circulation https://doi.org/10.1161/CIRCULATIONAHA.120.052359 (2020)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lim, G.B. Drugs targeting the sarcomere in heart failure and hypertrophic cardiomyopathy. Nat Rev Cardiol 18, 71 (2021). https://doi.org/10.1038/s41569-020-00488-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-020-00488-y